Estimating the cost of type 1 diabetes in the U.S.: A propensity score matching method

PLoS ONE

Volumn 5, Issue 7, 2010, Pages

  Tao, Betty ^a   Pietropaolo, Massimo ^b   Atkinson, Mark ^c   Schatz, Desmond ^d   Taylor, David ^a  

^a CNA   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

^d UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCOSE;

ADOLESCENT; ADULT; AGED; AMBULATORY CARE; ARTHRITIS; ARTICLE; CHILD; CONTROLLED STUDY; ECZEMA; EMERGENCY CARE; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH CARE COST; HEALTH CARE SYSTEM; HOSPITAL PATIENT; HUMAN; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; OUTCOME ASSESSMENT; PRESCRIPTION; SAMPLE SIZE; UNITED STATES; ECONOMICS; THEORETICAL MODEL;

DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; MALE; MODELS, THEORETICAL; UNITED STATES;

EID: 77955361316     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0011501     Document Type: Article

References (53)

1. Harris MI (1995) Classification, diagnostic criteria, and screening for diabetes. Diabetes in America 2: 95-1468.
2. American Diabetes Association (2008) Economic Costs of Diabetes in the U.S. in 2007. Diabetes Care 31: 596-615.
3. Centers for Disease Control and Prevention (2005) National Diabetes Fact Sheet, United States, 2005. Available at: www.cdc.gov/diabetes/pubs/pdf/ndfs_2005.pdf.
4. The DIAMOND Project Group (2006) Incidence and trends of childhood Type 1 diabetes worldwide 1990-1999. Diabetic Medicine 23: 857-866.
5. Agency for Healthcare Research and Quality Medical Expenditure Panel Survey (MEPS). Available at: http://www.meps.ahrq.gov/mepsweb.
6. Agency for Healthcare Research and Quality Total Expenses for Selected Conditions by Type of Service: United States 2005.
7. American Diabetes Association (2003) Economic Costs of Diabetes in the U.S. in 2002. Diabetes Care 26: 917-932.
8. Huang ES, Basu A, O'Grady M, Capretta JC (2009) Projecting the future diabetes population size and related costs for the U.S. Diabetes Care 32: 2225-2229.
9. Devol R, Bedroussian A, Charuworn A, Chatterjee A, Kim IK, et al. (2007) An Unhealthy America: The Economic Burden of Chronic Disease - Charting a New Course to Save Lives and Increase Productivity and Economic Growth.
10. Icks A, Holl RW, Giani G (2007) Economics in pediatric type 1 diabetes - results from recently published studies. Experimental and Clinical Endocrinology & Diabetes 115: 448-454.
11. Johnson JA, Pohar SL, Majumdar SR (2006) Health care use and costs in the decade after identification of type 1 and type 2 diabetes: a population-based study. Diabetes Care 29: 2403-2408.
12. Milton B, Holland P, Whitehead M (2006) The social and economic consequences of childhood-onset Type 1 diabetes mellitus across the lifecourse: a systematic review. Diabet Med 23: 821-829.
13. Dall TM, Mann SE, Zhang Y, Quick WW, Seifert RF, et al. (2009) Distinguishing the economic costs associated with type 1 and type 2 diabetes. Popul Health Manag 12: 103-110.
14. Rosenbaum Paul R, Rubin Donald B (1983) The central role of the propensity score in observational studies for causal effects. Biometrika 70: 41-55.
15. Akobundu E, Ju J, Blatt L, Mullins CD (2006) Cost-of-illness studies: a review of current methods. Pharmacoeconomics 24: 869-890.
16. Dorman Janice S, McCarthy Bridget J, O'Leary Leslie A, Koehler Anita N (1995) Risk Factors for Insulin Dependent Diabates.
17. Peng H, Hagopian W (2006) Environmental factors in the development of Type 1 diabetes. Rev Endocr Metab Disord 7: 149-162.
18. Leu RE, Schaub T (1983) Does smoking increase medical care expenditure? Social Science & Medicine 17: 1907-1914.
19. Manning WG, Keeler EB, Newhouse JP, Sloss EM, Wasserman J (1989) The taxes of sin: do smokers and drinkers pay their way? Journal of the American Medical Association 261: 1604-1609.
20. Hodgson TA (1992) Cigarette Smoking and Lifetime Medical Expenditures. The Milbank Quarterly 70: 81-125.
21. Heckman JJ, Ichimura H, Todd P (1997) Matching as an Econometric Evaluation Estimator: Evidence from Evaluation a Job Training Program. Review of Economic Studies 64: 605-654.
22. DiLiberti JH, Carver K, Parton E, Totka J, Mick G, et al. (2002) Stature at Time of Diagnosis of Type 1 Diabetes Mellitus. Pediatrics 109: 479-483.
23. Visalli N, Sebastiani L, Adorisio E, Conte A, De Cicco AL, et al. (2003) Environmental risk factors for type 1 diabetes in Rome and province. Archives of Disease in Childhood 88: 695-698.
24. Baser O (2006) Too Much Ado about Propensity Score Models? Comparing Methods of Propensity Score Matching. Value in Health 9: 377-385.
25. DiPrete TA, Gangl M (2004) Assessing Bias in the Estimation of Causal Effects: Rosenbaum Bounds on Matching Estimators and Instrumental Variables Estimation with Imperfect Instruments. Sociological Methodology 34: 271-310.
26. National Center for Health Statistics at the Centers for Disease Control and Prevention National Health and Nutrition Examination Survey (NHANES). Available at: http://www.cdc.gov/nchs/nhanes.htm.
27. National Center for Health Statistics at the Centers for Disease Control and Prevention National Health Interview Survey (NHIS). Available at: http://www.cdc.gov/nchs/nhis.htm.
28. Kahn ME (1998) Health and Labor Market Performance: The Case of Diabetes. Journal of Labor Economics 16: 878-99.
29. Koopman R, Mainous A, Diaz V, Geesey M (2005) Changes in Age at Diagnosis of Type 2 Diabetes Mellitus in the United States, 1988 to 2000. Annals of Family Medicine 3: 60-63.
30. Prior MJ, Prout T, Miller D, Ewart R, Kumar D (1993) C-peptide and the classification of diabetes mellitus patients in the Early Treatment Diabetic Retinopathy Study. Report number 6. The ETDRS Research Group. Ann Epidemiol 3: 9-17.
31. American Diabetes Association (2000) Type 2 Diabetes in Children and Adolescents. Diabetes Care 23: 381-389.
32. (2003) Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus - Diabetes Care. Available at: http://care.diabetesjournals.org/content/26/suppl_1/s5/T1.expansion. Accessed 4 April 2010.
33. Kuczmarski R, Ogden C, Guo S, et al. (2002) CDC growth charts for the United States: Methods and development. National Center for Health Statistics. Vital Health Stat.11 p.
34. Landin-Olsson M (2002) Latent autoimmune diabetes in adults. Ann N Y Acad Sci 958: 112-116.
35. Fourlanos S, Perry C, Stein MS, Stankovich J, Harrison LC, et al. (2006) A clinical screening tool identifies autoimmune diabetes in adults. Diabetes Care 29: 970-975.
36. Naik RG, Palmer JP (2003) Latent autoimmune diabetes in adults (LADA). Rev Endocr Metab Disord 4: 233-241.
37. Prando R, Cheli V, Melga P, Giusti R, Ciuchi E, et al. (1998) Is type 2 diabetes a different disease in obese and nonobese patients? Diabetes Care 21: 1680-1685.
38. Cusick M, Meleth A, Agron E, Fisher M, Reed G, et al. (2005) Associations of Mortality and Diabetes Complications in Patients With Type 1 and Type 2 Diabetes. Diabetes Care 28: 617-625.
39. National Institute of Diabetes and Digestive and Kidney Disease (NIDDK) All Type 1 Diabates Clinical Trials and Clinical Research. Available at: http://www.t1diabetes.nih.gov/T1D_CTCR/allstudies.asp. Accessed 9 April 2009.
40. Werner BFBrouwer, Marc AKoopmanschap, Frans FHRutten (1997) Productivity Costs Measurement Through Quality of Life? A Response to the Recommendation of the Washington Panel. Health Economics 6: 253-259.
41. Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL (2005) Methods for the economic evaluation of health care programmes. Oxford; New York; Auckland: Oxford University press.
42. Gu K, Cowie CC, Harris MI (1998) Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971-1993. DiabetesCare 21: 1138-1145.
43. Dahlquist G, Källén B (2005) Mortality in childhood-onset type 1 diabetes: a population-based study. Diabetes Care 28: 2384-2387.
44. Arias E (2007) United States life tables, 2004. Natl Vital Stat Rep 56: 1-39.
45. Rosenbaum PR (2002) Observational Studies. 2nd ed. Springer.
46. Thompson D, Edelsberg J, Colditz GA, Bird AP, Oster G (1999) Lifetime Health and Economic Consequences of Obesity. Arch Intern Med 159: 2177-2183.
47. Miguel A, Garcia-Ramom R, Perez-Contreras J, Gomez-Roldan C, Alvarino J, et al. (2002) Comorbidity and Mortality in Peritoneal Dialysis: A Comparative Study of Type 1 and 2 Diabetes versus Nondiabetic Patients. Nephron 90: 290-296.
48. Juutilainen A, Lehto S, Ronnemaa T, Pyorala K, Laakso M (2008) Similarity of the Impact of Type 1 and Type 2 Diabetes on Cardiovascular Mortality in Middle-Aged Subjects. Diabetes Care 31: 714-719.
49. Census Bureau (2001) US U.S. Summary: 2000 Census 2000 Profile.
50. Palmer JP, Fleming GA, Greenbaum CJ, Herold KC, Jansa LD, et al. (2004) Cpeptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001. Diabetes 53: 250-264.
51. JuvenileDiabetes Research Foundation InternationalGeneral Diabetes Fact Sheet. Available at: http://www.jdrf.org/index.cfm?fuseaction=home.viewPage&page_id=71927021-99EA-4D04-92E8463E607C84E1. Accessed 10 April 2010.
52. Centers for Disease Control and Prevention (CDC) (2007) National Diabetes Surveillance System. Available at: http://www.cdc.gov/diabetes/statistics/index.htm. Accessed 6 January 2008.
53. Keenan HA, Costacou T, Sun JK, Doria A, Cavellerano J, et al. (2007) Clinical factors associated with resistance to microvascular complications in diabetic patients of extreme disease duration: the 50-year medalist study. Diabetes Care 30: 1995-1997.